Effective Primary care practices that Enhance Recovery Trajectories after pneumonia (EXPERT)
增强肺炎后康复轨迹的有效初级保健实践(专家)
基本信息
- 批准号:10717618
- 负责人:
- 金额:$ 76.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-15 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdvance Care PlanningCOVID-19CaringClinical TrialsCritical CareDataData SetDiseaseElectronic Health RecordFocus GroupsGoalsHealthHealth systemHospitalistsHospitalizationHospitalsInformaticsInterventionInterviewKnowledgeLinkMalignant NeoplasmsMeasuresMedical SociologyMedicineMethodsMyocardial InfarctionOutcomePalliative CarePatient-Focused OutcomesPatientsPharmaceutical PreparationsPhysical therapyPneumoniaPrimary CareProcessRandomizedRecoveryResearchRespiratory FailureSepsisSiteStrokeStructureSurvivorsSystemTestingUnited StatesWorkclinical epidemiologydesignexperiencefollow-uphospital readmissionimplementation determinantsimprovedimproved outcomeinnovationinsightintervention refinementlong term recoverymedical specialtiesnovelpilot trialpost-COVID-19pragmatic randomized trialprimary care clinicianprimary care practiceprimary care servicesprimary care teamprocess improvementprototypepublic health prioritiestrial designuser centered design
项目摘要
Even before COVID-19, pneumonia with respiratory failure was a very common cause of hospitalization.
Unfortunately, many patients who survive pneumonia have persistent health problems for months or years
afterwards. The objective of this Effective Primary Care Practices that Enhance Recovery Trajectories
after Pneumonia (EXPERT) study is to use appreciative inquiry to help primary care clinicians take better care
of pneumonia patients in the 6 months after hospital–by taking a strengths-based approach for
transformational change to design and test a new systems-level intervention.
We will use a multi-methods approach wherein quantitative analysis of primary care actions and qualitative
interviews with expert primary care clinicians and patients are used to refine an innovative intervention in a
participatory prototyping pilot trial. The pilot trial targets mechanistic process outcomes linked to increased
hospital-free days for pneumonia survivors. Our team from primary care, hospitalist medicine, critical care,
palliative care, sepsis, informatics, clinical epidemiology, medical sociology, and clinical trials, will:
Aim 1: Quantitatively analyze granular EHR data to identify and refine candidate components for a
primary care intervention to improve post-pneumonia care. We will leverage large, feature-rich datasets
from our team’s 3 diverse health systems to identify specific orders, referrals, and billing services by primary
care clinicians that are substantially more frequent in the 6 months after pneumonia than before and temporally
associated with reduced subsequent hospitalization. Aim 2: Qualitatively analyze the experiential insights
of primary care clinicians and pneumonia survivors to identify and refine candidate components and
identify enablers and barriers for the post-pneumonia intervention. We will conduct semi-structured
interviews and focus groups with PCCs and pneumonia survivors across 4 states to evaluate key actions and
implementation factors for successful post-pneumonia recovery. Aim 3. Refine and pilot a novel
multicomponent primary care intervention to improve delivery of post-pneumonia care that will lead to
improved health outcomes for pneumonia survivors. We will use a novel stakeholder-engaged strategy of
participatory prototyping to iteratively optimize the intervention and evaluate its effects on target mechanistic
outcomes in an eight-site cluster randomized pilot trial design.
EXPERT’s research addresses a fundamental knowledge gap in post-pneumonia care, a public health priority.
We propose to use appreciative inquiry to help primary care do what primary care does well, and to optimize
an intervention that makes it easier for them to do so.
甚至在Covid-19之前,呼吸衰竭的肺炎都是住院的非常普遍的原因。
不幸的是,许多在肺炎中生存的患者持续存在数月或数年的健康问题
然后。这种有效的初级保健实践的目的是增强恢复轨迹
肺炎(专家)研究是在使用感激的询问来帮助初级保健临床医生接受更好的护理
住院后6个月内的肺炎患者 - 采取基于优势的方法
变革性的变革,设计和测试新的系统级干预措施。
我们将使用多方法方法,其中定量分析初级保健行动和定性
接受专业的初级保健临床医生和患者的访谈用于完善对A的创新干预措施
参与原型试验试验。试点试验目标机械过程结果与增加有关
肺炎存活的无医院日。我们的团队来自初级保健,医院医学,重症监护,
姑息治疗,败血症,信息,临床流行病学,医学社会学和临床试验,将:
AIM 1:定量分析颗粒EHR数据以识别和完善A的候选成分
初级保健干预措施以改善肺炎后护理。我们将利用大型,功能丰富的数据集
从我们团队的3个潜水员卫生系统中识别主要的订单,推荐和计费服务
随后在肺炎后的6个月内比以前且暂时更频繁的护理临床医生
与随后的住院减少有关。目标2:定性分析专家见解
初级保健临床医生和肺炎的生存,以识别和完善候选成分和
确定后营养后干预的推动因素和障碍。我们将进行半结构化
与PCC和肺炎表面访谈和焦点小组之间的四个州,以评估关键行动和
成功恢复后成功后的实施因素。目标3。完善和飞行员一本小说
多组分初级保健干预措施,以改善后营养后护理的交付,这将导致
改善了肺炎存活的健康结果。我们将使用一种新颖的利益相关者参与的策略
参与原型迭代优化干预措施并评估其对目标机械的影响
在八个站点群集随机试点试验设计中的结果。
专家的研究涉及公共卫生优先事项的pneumonia后护理方面的基本知识差距。
我们建议使用欣赏性询问来帮助初级保健做得很好,并优化
一种干预措施,使他们更容易这样做。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Catherine Lee Hough其他文献
Catherine Lee Hough的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Catherine Lee Hough', 18)}}的其他基金
Effect of randomization to neuromuscular blockade on physical functional impairment and recovery in ARDS
神经肌肉阻滞随机化对 ARDS 患者身体功能损伤和恢复的影响
- 批准号:
10249878 - 财政年份:2021
- 资助金额:
$ 76.16万 - 项目类别:
Mentored Patient Oriented Research in ARDS and Critical Illness Outcomes
指导 ARDS 和危重疾病结果中以患者为导向的研究
- 批准号:
10689129 - 财政年份:2020
- 资助金额:
$ 76.16万 - 项目类别:
Mentored Patient Oriented Research in ARDS and Critical Illness Outcomes
指导 ARDS 和危重疾病结果中以患者为导向的研究
- 批准号:
10491660 - 财政年份:2020
- 资助金额:
$ 76.16万 - 项目类别:
Pacific Northwest Clinical Center for the NHLBI PETAL Network
NHLBI PETAL 网络西北太平洋临床中心
- 批准号:
10225213 - 财政年份:2020
- 资助金额:
$ 76.16万 - 项目类别:
Mentored Patient Oriented Research in ARDS and Critical Illness Outcomes
指导 ARDS 和危重疾病结果中以患者为导向的研究
- 批准号:
10249623 - 财政年份:2020
- 资助金额:
$ 76.16万 - 项目类别:
Mentored Patient Oriented Research in ARDS and Critical Illness Outcomes
指导 ARDS 和危重疾病结果中以患者为导向的研究
- 批准号:
9955342 - 财政年份:2020
- 资助金额:
$ 76.16万 - 项目类别:
Oregon Clinical and Translational Research Institute KL2 Program
俄勒冈临床和转化研究所 KL2 项目
- 批准号:
10197248 - 财政年份:2017
- 资助金额:
$ 76.16万 - 项目类别:
Effect of randomization to neuromuscular blockade on physical functional impairment and recovery in ARDS
神经肌肉阻滞随机化对 ARDS 患者身体功能损伤和恢复的影响
- 批准号:
9080061 - 财政年份:2016
- 资助金额:
$ 76.16万 - 项目类别:
相似海外基金
Meeting the Challenges of COVID-19 by Expanding the Reach of Palliative Care: Proactive Advance Care Planning with Videos for the Elderly and all Patients with Dementia
通过扩大姑息治疗的范围来应对 COVID-19 的挑战:为老年人和所有痴呆症患者提供视频的主动预先护理计划
- 批准号:
10784057 - 财政年份:2023
- 资助金额:
$ 76.16万 - 项目类别:
Improving Serious Illness Care for Underserved Populations: Patient and Caregiver Experience with Tele-Palliative Care
改善服务不足人群的重病护理:患者和护理人员的远程姑息护理体验
- 批准号:
10635741 - 财政年份:2023
- 资助金额:
$ 76.16万 - 项目类别:
A Multisite Randomized Controlled Trial of EMPOWER for Family Surrogates of Critically Ill Patients
EMPOWER 对危重患者家庭代理人的多中心随机对照试验
- 批准号:
10367277 - 财政年份:2022
- 资助金额:
$ 76.16万 - 项目类别:
Improving patient care in severe acute brain injury: a web/mobile/tablet-based communication and decision support tool for clinicians and families in the neuro-ICU
改善严重急性脑损伤患者的护理:为神经重症监护病房的临床医生和家属提供基于网络/移动/平板电脑的通信和决策支持工具
- 批准号:
10589141 - 财政年份:2022
- 资助金额:
$ 76.16万 - 项目类别:
A Multisite Randomized Controlled Trial of EMPOWER for Family Surrogates of Critically Ill Patients
EMPOWER 对危重患者家庭代理人的多中心随机对照试验
- 批准号:
10599859 - 财政年份:2022
- 资助金额:
$ 76.16万 - 项目类别: